Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensCell Lines for BBB Modeling
- Immortalized Cells for BBB ModelingPrimary Cells for BBB ModelingStem Cells for BBB ModelingProteins & Peptides for Stroke ResearchOnline Inquiry
Human SLC25A12 ELISA Kit (AC2690)
Cat.#: ASET-1279
Specifications
Description Human SLC25A12 ELISA Kit, a 90-minute assay kit, allows for the in vitro quantitative determination of human SLC25A12 concentrations in serum, plasma, and other biological fluids. Size 96T Sample Type Serum, plasma or other biological fluids. Reactivity Human Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 4.62 ng/L Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 75-1200 ng/L Assay Time ~90 min Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-1086 Rat DRD4 ELISA Kit (AC2497) Quantitative inquiry ASET-2526 Human Estrogen Receptor alpha ELISA Kit (AC3937) Quantitative inquiry ASET-1947 Human Wnt3a ELISA Kit (AC3358) Quantitative inquiry ASET-1525 Human beta Catenin ELISA Kit (AC2936) Quantitative inquiry ASET-2334 Mouse ACTH ELISA Kit (AC3745) Quantitative inquiry ASET-1068 Mouse Wnt10b ELISA Kit (AC2479) Quantitative inquiry ASET-1538 Rat FOXO1A ELISA Kit (AC2949) Quantitative inquiry ASET-2281 Human Neurotensin ELISA Kit (AC3692) Quantitative inquiry ASET-1423 Monkey Leptin ELISA Kit (AC2834) Quantitative inquiry ASET-2390 Human CCR5 ELISA Kit (AC3801) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket